UnitedHealth Group (UNH)
$257.70
2.90 (1.11%)
UNH Stock Quote Delayed 15 Minutes
Previous Close
$260.60
Market Cap
247.64B
PE Ratio
22.68
EPS
11.36
Volume (Avg. Vol.)
1.96M
Day's Range
257.05 - 262.72
52-Week Range
208.07 - 287.94
Dividend & Yield
3.30 (1.28%)
UNH Stock Predictions, Articles, and UnitedHealth Group News
UnitedHealth Earnings: UNH Stock Dips Despite Q2 Beat
UnitedHealth earnings for the second quarter of 2019 have UNH stock falling, despite the company's positive results for the period.
Dow Jones Today: A Lackluster Showing
In advance of some important earnings reports coming Thursday from some big-name members of the Dow Jones Industrial Average, the major U.S. equity indexes did a whole lot of nothing Wednesday.
3 Big Stock Charts for Friday: HollyFrontier, Activision Blizzard and Vertex Pharmaceuticals
The stock charts of HollyFrontier, Activision Blizzard and Vertex Pharmaceuticals are poised to end the trading week in a pivotal situation.
Dow Jones Today: More Fed Fun, but Healthcare Weakness Caps Gains
While it appears unlikely that the Fed will lower rates by 50 basis points this month, markets are increasingly comfortable with the notion of 0.25% reduction followed by more of the same in September.
Dow Jones Today: Why These Big Names Got Drubbed
Something that has been discussed here in recent days is the shift away from trade concerns to company-specific issues. That was very much the case today as a slew of big names in the Dow were punished for a variety of stock-specific reasons. Let's have a look at some of those names.
Dow Jones Today: Maybe We’re Getting Somewhere
Despite the jitters going into Saturday's G20 meeting, the Dow Jones today was aided by a decent earnings report before the bell from WBA.
3 Healthcare Stocks to Buy With the Market Near All-Time Highs
PFE, JNJ and UNH are three healthcare stocks to buy even up near all-time market highs. Each for its own reasons.
Dow Jones Today: A Typical Summer Friday
Long-term investors can find some solace with an article in Barron's today indicating Dow 30,000 could arrive sooner than expected.
Dow Jones Today: Stocks Almost Had Some Fed Fun
While the Federal Reserve did not cut rates, stocks were still feeling optimistic. Several big names were up in the Dow Jones today.
CVS Stock Has More Going for It Than Just a 3.69% Dividend Yield
A judge is challenging the CVS Health-Aetna deal and the drug store sector is out of favor. So when will the discount on CVS stock end?
Dow Jones Today: Jobs Report Was a Dud, But Stocks Didn’t Mind
Comments from President Trump regarding Mexico potentially avoiding trade tariffs set to go into effect next week were among the catalysts for stocks today. Trump is pushing Mexico to buy more from U.S. farmers, saying that if Mexico cooperates, tariffs could be avoided.
Why Is Bristol-Myers Near 52-Week Lows?
Investors are punishing Bristol-Myers on the markets more than they should. BMY stock's acquisition of Celgene isn't the only reason.
If You Have the Stomach, Start Buying UNH Stock as It Bottoms Out
First, is the opportunity cost of patiently holding UNH stock when it’s obviously facing severe headwinds, worth it? After all, there are so many other stocks you could buy with better near-term prospects.
Wednesday’s Vital Data: Proctor & Gamble, UnitedHealth Group and Qualcomm
Options trading was buzzing in Proctor & Gamble, UnitedHealth Group and Qualcomm on Tuesday. Here are the metrics that matter moving forward.
Trade of the Day: UnitedHealth Stock Is Primed for a Counter-Trend Trade
UNH stock has fared worse than the average stock in the healthcare sector, but UnitedHealth is now reaching record oversold readings, which sets up a counter-trend trade.
3 Big Stock Charts for Wednesday: Western Digital, UnitedHealth Group and Bank of America
The stock charts of UNH, WDC and BAC stock are at pivot points headed into the midpoint of the trading week.
UnitedHealth Earnings: Why UNH Stock Is Sliding Lower
UnitedHealth earnings for the first quarter of 2019 have UNH stock falling on Tuesday, despite the company beating EPS and revenue estimates.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
C
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!
